Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics
- PMID: 2318215
- DOI: 10.1007/BF01963634
Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics
Abstract
Enterococci belonging to various species resistant to vancomycin and related cyclic glycopeptide antibiotics have been isolated from hospitalized patients in France, the UK and the USA. All such strains examined display inducible synthesis of a membrane protein associated with resistance. The mechanism by which the membrane protein acts has not been definitively established, but it may block the access of the antibiotic to its peptidoglycan target. That the protein could be a bypass enzyme has not been ruled out. Transfer of glycopeptide resistance by conjugation to either Enterococcus faecium or Enterococcus faecalis and by transformation of Streptococcus sanguis Challis has been reported. The structural and regulatory genes encoding this resistance can be localized on plasmid and, apparently, chromosomal DNA. The plasmids encoding this resistance appear to differ from each other and have variable host ranges, but share at least some DNA sequence homology.
Similar articles
-
Resistance of enterococci to aminoglycosides and glycopeptides.Clin Infect Dis. 1992 Sep;15(3):495-501. doi: 10.1093/clind/15.3.495. Clin Infect Dis. 1992. PMID: 1520800 Review.
-
Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.Antimicrob Agents Chemother. 1989 Jan;33(1):10-5. doi: 10.1128/AAC.33.1.10. Antimicrob Agents Chemother. 1989. PMID: 2523687 Free PMC article.
-
[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].Przegl Lek. 2004;61(5):473-6. Przegl Lek. 2004. PMID: 15515808 Polish.
-
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.Drugs. 1997;54 Suppl 6:11-20. doi: 10.2165/00003495-199700546-00005. Drugs. 1997. PMID: 9474477
-
Enterococci and vancomycin resistance.Clin Infect Dis. 1998 Aug;27 Suppl 1:S75-83. doi: 10.1086/514910. Clin Infect Dis. 1998. PMID: 9710674 Review.
Cited by
-
Characterization of glycopeptide-resistant enterococci from U.S. hospitals.Antimicrob Agents Chemother. 1993 Nov;37(11):2311-7. doi: 10.1128/AAC.37.11.2311. Antimicrob Agents Chemother. 1993. PMID: 8285611 Free PMC article.
-
Increasing problems in the therapy of enterococcal infections.Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):409-12. doi: 10.1007/BF01967433. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8359159 No abstract available.
-
Increasing resistance of enterococci to ciprofloxacin.Antimicrob Agents Chemother. 1992 Nov;36(11):2533-5. doi: 10.1128/AAC.36.11.2533. Antimicrob Agents Chemother. 1992. PMID: 1489199 Free PMC article.
-
In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.Antimicrob Agents Chemother. 1992 Feb;36(2):331-8. doi: 10.1128/AAC.36.2.331. Antimicrob Agents Chemother. 1992. PMID: 1534977 Free PMC article.
-
Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients.J Clin Microbiol. 1995 Nov;33(11):2842-6. doi: 10.1128/jcm.33.11.2842-2846.1995. J Clin Microbiol. 1995. PMID: 8576330 Free PMC article.